# Cardiovascular remodeling: key mechanisms and clinical implications linking sarcopenia and heart failure

## TL;DR

This paper explores how heart failure and muscle loss are linked through shared mechanisms like inflammation and how this understanding can lead to better treatments.

## Contribution

The paper provides a unified framework for the mechanistic links between sarcopenia and heart failure, highlighting novel therapeutic targets.

## Key findings

- Cardiovascular remodeling mediates the bidirectional relationship between sarcopenia and heart failure.
- Shared mechanisms include chronic inflammation, oxidative stress, and insulin resistance.
- Targeting these pathways could improve outcomes for both conditions.

## Abstract

Sarcopenia and heart failure (HF) are interconnected through a bidirectional relationship in which cardiovascular remodeling serves as a critical mediator. This review examines the shared pathophysiological mechanisms—such as chronic inflammation, oxidative stress, and insulin resistance—that underlie both conditions. By integrating recent clinical and experimental evidence, we emphasize the role of cardiovascular remodeling in aggravating muscle loss in sarcopenia and cardiac dysfunction in HF. Furthermore, we discuss novel therapeutic targets directed at disrupting these common pathways. This analysis offers a unified framework for understanding the mechanistic links between sarcopenia and HF, with implications for future research and clinical strategies aimed at enhancing patient outcomes.